Drug:
Reaction: ERYTHEMA
20260101 - 20261231
No. 901 - 1000
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 901 | 26829374 |
JP |
78 | 2 |
Liver disorder, Jaundice, Chromaturia, Faeces discoloured, Faeces discoloured, Yellow skin, Intentional underdose, Erythema, Pruritus, |
||||
AVACOPAN, AVACOPAN, ALENDRONATE SODIUM, ALENDRONATE SODIUM TABLET, AZATHIOPRINE, VONOPRAZAN FUMARATE, COLCHICINE, |
||||
| 902 | 26819456 |
JP |
50 | 2 |
Drug eruption, Purpura, Erythema, Papule, Pyrexia, |
||||
IMATINIB MESYLATE, IMATINIB, IMATINIB MESYLATE, IMATINIB, IMATINIB MESYLATE, IMATINIB, IMATINIB MESYLATE, IMATINIB, |
||||
| 903 | 26819607 |
US |
63 | 2 |
Urticaria, Pruritus, Inflammation, Erythema, Off label use, |
||||
OMALIZUMAB, OXYCODONE, |
||||
| 904 | 26819616 |
JP |
50 | |
Erythema, Eczema, Urticaria, Intentional dose omission, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, AZATHIOPRINE, AZATHIOPRINE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE, ESOMEPRAZOLE MAGNESIUM DIHYDRATE, ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, ALENDRONATE SODIUM, ALENDRONATE SODIUM TABLET, PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, METRONIDAZOLE, GANCICLOVIR SODIUM, GANCICLOVIR, LEMBOREXANT, ZINC ACETATE, |
||||
| 905 | 26819622 |
EU |
69 | 2 |
Thrombosis, Adverse reaction, Chest discomfort, Erythema, Rash, Insomnia, Diarrhoea, Tension, Anxiety, Off label use, Gene mutation, |
||||
AMIVANTAMAB-VMJW, AMIVANTAMAB-VMJW, AMIVANTAMAB-VMJW, AMIVANTAMAB-VMJW, AMIVANTAMAB-VMJW, OSIMERTINIB, PEMETREXED, PEMETREXED DISODIUM, DOXYCYCLINE, DOXYCYCLINE HYCLATE, FOLIC ACID, FOLIC ACID, CARBOPLATIN, |
||||
| 906 | 26819786 |
US |
2 | |
Hypersensitivity, Erythema, Swelling face, Swollen tongue, Feeling hot, |
||||
BECLOMETHASONE DIPROPIONATE HFA, |
||||
| 907 | 26819830 |
US |
15 | 2 |
Psoriasis, Erythema, Pruritus, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 908 | 26819997 |
US |
76 | 2 |
Glossodynia, Constipation, Pruritus, Erythema, Fatigue, Eyelid skin dryness, Tongue blistering, Ocular hyperaemia, Eye pruritus, Skin fissures, Skin swelling, Chapped lips, Scratch, |
||||
NIVOLUMAB AND HYALURONIDASE-NVHY, CABOZANTINIB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CARVEDILOL, HYDROCHLOROTHIAZIDE, LOSARTAN POTASSIUM, ATORVASTATIN CALCIUM, FISH OIL, |
||||
| 909 | 26820108 |
US |
51 | 1 |
Constipation, Injection site pain, Eczema, Erythema, |
||||
DUPILUMAB, DUPILUMAB, TERBINAFINE HYDROCHLORIDE, TERBINAFINE, TERBINAFINE HYDROCHLORIDE TABLET, |
||||
| 910 | 26820173 |
US |
2 | |
Anxiety, Erythema, Feeling abnormal, Peripheral swelling, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, FOLIC ACID, ENOXAPARIN SODIUM, SILDENAFIL CITRATE, SILDENAFIL, |
||||
| 911 | 26820190 |
EU |
72 | 1 |
Erythema, Concomitant disease aggravated, Eosinophilia, Acute kidney injury, |
||||
EMPAGLIFLOZIN, |
||||
| 912 | 26820230 |
EU |
82 | |
Dermatitis exfoliative generalised, Skin exfoliation, Erythema, Pruritus, Skin exfoliation, Therapy partial responder, Therapy change, |
||||
MOGAMULIZUMAB-KPKC, |
||||
| 913 | 26820340 |
US |
59 | 2 |
Dry skin, Skin swelling, Erythema, Pain of skin, |
||||
DUPILUMAB, |
||||
| 914 | 26820379 |
CA |
53 | 1 |
Blood pressure increased, Bone cancer, Second primary malignancy, Bladder cancer, Cyst, Arthropod bite, Acne, Prostatic specific antigen increased, Productive cough, Oedema peripheral, Movement disorder, Musculoskeletal stiffness, Oncologic complication, Pain in extremity, Hot flush, Gait disturbance, Heart rate increased, Carcinoid tumour, Malignant neoplasm progression, Metastases to prostate, Metastases to chest wall, Injection site pain, Prostate cancer, Metastases to pelvis, Intestinal metastasis, Pruritus, Arthralgia, Fatigue, Erythema, Gait inability, Headache, Pain in extremity, General physical health deterioration, Therapeutic response decreased, Muscular weakness, Pelvic pain, Nasopharyngitis, Rhinorrhoea, Crystal arthropathy, Body temperature abnormal, Injection site pain, Hypoaesthesia, Headache, Dizziness, Blood pressure decreased, Inappropriate schedule of product administration, Needle issue, Constipation, |
||||
AMLODIPINE BESYLATE, AMLODIPINE BESYLATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, ROSUVASTATIN, LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, ERGOCALCIFEROL, ERGOCALCIFEROL, MORPHINE, |
||||
| 915 | 26820437 |
US |
1 | |
Blindness, Erythema, Skin exfoliation, Rash, |
||||
FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, DUPILUMAB, |
||||
| 916 | 26820629 |
CA |
54 | |
SARS-CoV-2 test positive, Erythema, Pain, Pruritus, Vertigo, Dizziness, Drug ineffective, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, METHYLPREDNISOLONE, |
||||
| 917 | 26820665 |
US |
4 | 2 |
Toxic epidermal necrolysis, Stevens-Johnson syndrome, Skin exfoliation, Blister, Skin erosion, Erythema, Skin discolouration, Lip oedema, Eye oedema, Mouth haemorrhage, Vaginal haemorrhage, Frequent bowel movements, Haematuria, |
||||
CEFEPIME HYDROCHLORIDE, CEFEPIME, CEFEPIME HYDROCHLORIDE, CEFEPIME, VORICONAZOLE, VORICONAZOLE INJECTION, VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM, PIPERACILLIN AND TAZOBACTAM, PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, PANTOPRAZOLE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, MICAFUNGIN, MICAFUNGIN SODIUM, FUROSEMIDE, CALCIUM GLUCONATE, NOREPINEPHRINE (BITARTRATE), NOREPINEPHRINE, NOREPINEPHRINE BITARTRATE, ALBUTEROL SULFATE, ALBUTEROL, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM BICARBONATE, SODIUM BICARBONATE, INJECTION, SODIUM BICARBONATE INJECTION,, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, |
||||
| 918 | 26820920 |
AU |
75 | 1 |
Urticaria, Hypertension, Drug hypersensitivity, Pruritus, Chest pain, Dyspnoea, Erythema, Rash erythematous, Rash papular, Rash macular, Pallor, Heart rate increased, Respiratory rate increased, Urticaria, Rash pruritic, Malaise, Tongue pruritus, Paraesthesia oral, Pruritus, Urticaria, Malaise, Rash, Hypersensitivity, |
||||
PREDNISONE, PREDNISONE, PYRIDOSTIGMINE BROMIDE ORAL, PYRIDOSTIGMINE BROMIDE ORAL, MYCOPHENOLIC ACID, MYCOPHENILIC ACID, ROSUVASTATIN, ACETAMINOPHEN, DEXTROMETHORPHAN HBR, ACETAMINOPHEN AND DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN AND CAFFEINE, ACETAMINOPHEN AND PHENYLEPRINE HCL, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HBR, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, |
||||
| 919 | 26821039 |
US |
1 | |
Erythema, Skin exfoliation, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 920 | 26821124 |
EU |
56 | 1 |
Cough, Erythema, Stridor, Dyspnoea, Urticaria, |
||||
OXALIPLATIN, |
||||
| 921 | 26821359 |
US |
44 | 2 |
Swelling, Erythema, Allergy to arthropod sting, |
||||
DUPILUMAB, |
||||
| 922 | 26821361 |
US |
19 | 1 |
Erythema, Dry skin, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 923 | 26821368 |
US |
3 | 2 |
Dry skin, Rash erythematous, Skin hyperpigmentation, Sleep disorder due to a general medical condition, Erythema, Pruritus, Eczema, Pruritus, |
||||
DUPILUMAB, |
||||
| 924 | 26821373 |
US |
19 | 2 |
Musculoskeletal stiffness, Dermatitis atopic, Erythema, |
||||
DUPILUMAB, |
||||
| 925 | 26821719 |
US |
2 | |
Dry skin, Erythema, |
||||
DUPILUMAB, |
||||
| 926 | 26822072 |
EU |
23 | 1 |
Erythema, Lacrimation increased, Pruritus, Rhinorrhoea, |
||||
IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 927 | 26822089 |
US |
30 | 1 |
Neurodermatitis, Eczema, Erythema, Pruritus, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 928 | 26822148 |
US |
88 | 2 |
Erythema, Pruritus, Therapeutic response shortened, Inappropriate schedule of product administration, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 929 | 26822203 |
US |
64 | 1 |
Gastrooesophageal reflux disease, Loss of personal independence in daily activities, Thyroid mass, Erythema, Somnolence, Condition aggravated, Dizziness, Nausea, Blood pressure decreased, Fatigue, |
||||
APOMORPHINE HYDROCHLORIDE, APOMORPHINE HYDROCHLORIDE, APOMORPHINE HYDROCHLORIDE, PANTOPRAZOLE SODIUM, |
||||
| 930 | 26822313 |
US |
62 | 1 |
Freezing phenomenon, Injection site bruising, Fatigue, Insomnia, Dyskinesia, Headache, Injection site nodule, Injection site pruritus, Erythema, Injection site reaction, Device connection issue, Device issue, |
||||
APOMORPHINE HYDROCHLORIDE, APOMORPHINE HYDROCHLORIDE, APOMORPHINE HYDROCHLORIDE, APOMORPHINE HYDROCHLORIDE, APOMORPHINE HYDROCHLORIDE, APOMORPHINE HYDROCHLORIDE, |
||||
| 931 | 26823352 |
BR |
46 | 2 |
Intestinal metastasis, Acute oesophageal mucosal lesion, Hepatic mass, Lung neoplasm, Erythema, Alopecia, Skin irritation, Fatigue, Nausea, Dry skin, Discouragement, Stomatitis, Acne, Inflammation, Skin fissures, Paronychia, Hypoaesthesia, Skin irritation, Decreased immune responsiveness, |
||||
PANITUMUMAB, RIVAROXABAN, PREGABALIN, |
||||
| 932 | 26823356 |
47 | 2 | |
Pruritus, Erythema, Urticaria, Swelling face, |
||||
| 933 | 26823579 |
CN |
62 | 2 |
Drug eruption, Erythema, Papule, Pruritus, Peripheral swelling, Blood pressure increased, Haemoglobin decreased, Epiglottitis, Blood triglycerides increased, |
||||
CARBAMAZEPINE, |
||||
| 934 | 26823727 |
EU |
1 | |
Cardiovascular disorder, Blood pressure abnormal, Disturbance in attention, Illness, Orthostatic hypotension, Asthenia, Erythema, Poor peripheral circulation, |
||||
TEZEPELUMAB-EKKO, TEZEPELUMAB-EKKO, |
||||
| 935 | 26823841 |
53 | 2 | |
Syncope, Hypotension, Erythema, Pruritus, Rash, Dizziness, Vomiting, Nausea, Palpitations, |
||||
NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 936 | 26823876 |
EU |
71 | 1 |
Erythema, |
||||
FLUOROURACIL, |
||||
| 937 | 26824098 |
27 | 2 | |
Steroid withdrawal syndrome, Skin exfoliation, Eczema, Erythema, Skin burning sensation, |
||||
MOMETASONE FUROATE, MOMETASONE, HYDROCORTISONE ACETATE, |
||||
| 938 | 26828013 |
45 | 2 | |
Pruritus genital, Pruritus, Throat irritation, Erythema, Infusion related reaction, |
||||
OCRELIZUMAB, OCRELIZUMAB, |
||||
| 939 | 26843278 |
23 | 2 | |
Injection site pain, Injection site haemorrhage, Injection site bruising, Injection site mass, Concussion, Vertigo, Dysphagia, Erythema, Hypoaesthesia, Cardiovascular insufficiency, Therapy cessation, Depression, Anxiety, |
||||
GLATIRAMER, |
||||
| 940 | 26817777 |
US |
8 | 1 |
Sleep disorder, Erythema, |
||||
DUPILUMAB, |
||||
| 941 | 26817834 |
US |
103 | 2 |
Erythema, |
||||
DUPILUMAB, |
||||
| 942 | 26817850 |
US |
1 | |
Eczema, Erythema, |
||||
DUPILUMAB, |
||||
| 943 | 26817873 |
US |
32 | 2 |
Eczema, Pruritus, Erythema, Dry skin, Ocular hyperaemia, Conjunctivitis, Eye pruritus, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 944 | 26818049 |
EU |
73 | 2 |
Oedema peripheral, Erythema, Hepatic cytolysis, Cholestasis, |
||||
FULVESTRANT, ABEMACICLIB, |
||||
| 945 | 26818090 |
US |
1 | |
Dermatitis, Erythema, |
||||
DUPILUMAB, |
||||
| 946 | 26818114 |
US |
54 | 1 |
Skin irritation, Rash, Dizziness, Hypotension, Erythema, Rash macular, Rash pruritic, Pain of skin, |
||||
RISANKIZUMAB-RZAA, |
||||
| 947 | 26818147 |
US |
1 | 2 |
Rhinorrhoea, Eczema, Erythema, Pruritus, |
||||
DUPILUMAB, |
||||
| 948 | 26818253 |
US |
65 | 1 |
Pustule, Erythema, Petechiae, Skin reaction, Rash, |
||||
LINEZOLID, LINEZOLID, LINEZOLID, FERROUS SULFATE, GLIPIZIDE, SITAGLIPTIN, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, TAMSULOSIN HYDROCHLORIDE, APIXABAN, |
||||
| 949 | 26818274 |
US |
84 | 1 |
Hordeolum, Eye discharge, Eczema, Erythema, Skin exfoliation, Rash, Skin fissures, Blister, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 950 | 26818283 |
US |
2 | |
Injection site swelling, Injection site erythema, Swelling of eyelid, Pruritus, Erythema, Dry skin, |
||||
DUPILUMAB, |
||||
| 951 | 26818387 |
US |
71 | 2 |
Skin swelling, Erythema, |
||||
DUPILUMAB, |
||||
| 952 | 26818464 |
US |
24 | 1 |
Urticaria, Erythema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 953 | 26818508 |
US |
74 | 1 |
Hyperhidrosis, Dizziness, Injection site rash, Injection site pruritus, Erythema, Off label use of device, |
||||
INSULIN GLARGINE, |
||||
| 954 | 26818645 |
US |
58 | 2 |
Rash pruritic, Erythema, Dry skin, |
||||
DUPILUMAB, |
||||
| 955 | 26819029 |
US |
72 | 1 |
Urticaria, Dyspnoea, Vision blurred, Cough, Dizziness, Heart rate increased, Pruritus, Rash, Respiration abnormal, Erythema, Chest pain, Fatigue, Asthenia, Memory impairment, Product confusion, Off label use, Inappropriate schedule of product administration, Product dose omission issue, Product storage error, |
||||
CABOTEGRAVIR AND RILPIVIRINE, CABOTEGRAVIR AND RILPIVIRINE, CABOTEGRAVIR AND RILPIVIRINE, MEPOLIZUMAB, MEPOLIZUMAB, ALBUTEROL SULFATE, BUPROPION HYDROCHLORIDE, FUROSEMIDE, FUROSEMIDE, CARVEDILOL, CARVEDILOL, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, BUDESONIDE, AZELASTINE, SPIRONOLACTONE, SACUBITRIL AND VALSARTAN, ROSUVASTATIN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, PREDNISONE, EMPAGLIFLOZIN, EZETIMIBE, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, SILDENAFIL CITRATE, SILDENAFIL, SILDENAFIL POWDER,, |
||||
| 956 | 26819162 |
US |
33 | 2 |
Skin exfoliation, Erythema, Rash, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 957 | 26819226 |
US |
72 | 1 |
Urticaria, Dyspnoea, Vision blurred, Cough, Dizziness, Heart rate increased, Pruritus, Rash, Respiration abnormal, Erythema, Chest pain, Fatigue, Asthenia, Memory impairment, Product confusion, Off label use, Inappropriate schedule of product administration, Product dose omission issue, Product storage error, |
||||
MEPOLIZUMAB, MEPOLIZUMAB, CABOTEGRAVIR AND RILPIVIRINE, CABOTEGRAVIR AND RILPIVIRINE, CABOTEGRAVIR AND RILPIVIRINE, ALBUTEROL SULFATE, BUPROPION HYDROCHLORIDE, FUROSEMIDE, FUROSEMIDE, CARVEDILOL, CARVEDILOL, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, BUDESONIDE, AZELASTINE, SPIRONOLACTONE, SACUBITRIL AND VALSARTAN, ROSUVASTATIN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, PREDNISONE, EMPAGLIFLOZIN, EZETIMIBE, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, SILDENAFIL CITRATE, SILDENAFIL, SILDENAFIL POWDER,, |
||||
| 958 | 26819276 |
EU |
40 | 1 |
Neuroendocrine tumour, Erythropenia, Haemoglobin decreased, Nausea, Chest discomfort, Hypochromic anaemia, Iron deficiency anaemia, Pruritus, Erythema, Abdominal pain, Microcytic anaemia, |
||||
UPADACITINIB, UPADACITINIB, UPADACITINIB, UPADACITINIB, MELOXICAM, |
||||
| 959 | 26819298 |
US |
2 | |
Post-traumatic stress disorder, Anxiety, Tachycardia, Hypertension, Erythema, Malaise, Insomnia, Product taste abnormal, |
||||
ALPRAZOLAM, |
||||
| 960 | 26813058 |
EU |
57 | 2 |
Erythema, Sepsis, Cellulitis, Pyrexia, Cellulitis, |
||||
FULVESTRANT, EVEROLIMUS, EVEROLIMUS TABLETS, |
||||
| 961 | 26813130 |
CN |
14 | 2 |
Rash maculo-papular, Pruritus, Erythema, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 962 | 26813247 |
AU |
19 | 1 |
Lymphadenopathy, Erythema, Acanthosis, Inflammation, Lymphocytic infiltration, |
||||
DUPILUMAB, |
||||
| 963 | 26813253 |
US |
38 | 2 |
Rash, Pruritus, Erythema, |
||||
DUPILUMAB, |
||||
| 964 | 26813448 |
US |
||
Rash vesicular, Acne, Erythema, Psoriasis, Psoriatic arthropathy, |
||||
| 965 | 26813601 |
EU |
57 | 1 |
Erythema, Feeling hot, |
||||
INFLIXIMAB, |
||||
| 966 | 26813746 |
CA |
62 | 2 |
Dyspnoea, Chest discomfort, Erythema, Oxygen therapy, Cyanosis, Livedo reticularis, |
||||
PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), CARBOPLATIN, |
||||
| 967 | 26813749 |
EU |
61 | 1 |
Oral pruritus, Erythema, |
||||
OXALIPLATIN, |
||||
| 968 | 26813842 |
US |
2 | |
Erythema, Wrong technique in product usage process, Product closure removal difficult, |
||||
LATANOPROST, |
||||
| 969 | 26813848 |
US |
45 | 2 |
Skin burning sensation, Pruritus, Erythema, |
||||
ABATACEPT, ABATACEPT, |
||||
| 970 | 26814011 |
US |
66 | 2 |
Rash macular, Erythema, Urticaria, |
||||
TIRZEPATIDE, |
||||
| 971 | 26814358 |
CN |
52 | 2 |
Blood pressure immeasurable, Palpitations, Hyperhidrosis, Muscular weakness, Pallor, Rash, Erythema, |
||||
IOHEXOL, |
||||
| 972 | 26814424 |
US |
63 | 2 |
Photosensitivity reaction, Decreased immune responsiveness, Feeling hot, Erythema, Photosensitivity reaction, |
||||
| 973 | 26814582 |
US |
62 | 2 |
Erythema, Pruritus, Urticaria, Arthralgia, Peripheral swelling, Pain in extremity, Hypersensitivity, |
||||
DUPILUMAB, DUPILUMAB, OMALIZUMAB, |
||||
| 974 | 26814611 |
US |
70 | 1 |
Blister, Pruritus, Erythema, Dermatitis, Drug ineffective, |
||||
DUPILUMAB, |
||||
| 975 | 26814722 |
US |
78 | 2 |
Peripheral swelling, Erythema, Pruritus, Skin irritation, Incorrect dose administered, |
||||
ACETAMINOPHEN, ACETAMINOPHEN, |
||||
| 976 | 26814816 |
US |
35 | |
Rash, Erythema, |
||||
| 977 | 26815062 |
US |
58 | 2 |
Pruritus, Oral discomfort, Erythema, Dysphagia, |
||||
TOCILIZUMAB, |
||||
| 978 | 26815157 |
US |
1 | 2 |
Dermatitis atopic, Skin irritation, Dry skin, Erythema, Pruritus, |
||||
DUPILUMAB, |
||||
| 979 | 26815260 |
34 | 2 | |
Erythema, Urticaria, Pruritus, |
||||
IRON SUCROSE, |
||||
| 980 | 26815573 |
US |
2 | |
Dermatitis atopic, Erythema, |
||||
DUPILUMAB, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, PROGESTERONE, TESTOSTERONE CYPIONATE, VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, |
||||
| 981 | 26815916 |
US |
1 | |
Erythema, Periorbital swelling, |
||||
DUPILUMAB, |
||||
| 982 | 26816167 |
EG |
||
Flushing, Swelling, Drug hypersensitivity, Erythema, Infusion related reaction, |
||||
PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), CARBOPLATIN, CARBOPLATIN, |
||||
| 983 | 26816589 |
36 | 2 | |
Erythema, Swelling of eyelid, Peripheral swelling, Pruritus, Blood pressure increased, Incorrect product administration duration, |
||||
IRON SUCROSE, IRON SUCROSE, |
||||
| 984 | 26816743 |
US |
2 | |
Erythema, Pruritus, Skin burning sensation, Psoriasis, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, |
||||
| 985 | 26817645 |
US |
2 | |
Cellulitis, Pain in extremity, Erythema, Peripheral swelling, |
||||
AGALSIDASE BETA, ALPRAZOLAM, CLINDAMYCIN AND BENZOYL PEROXIDE, SPIRONOLACTONE, LISDEXAMFETAMINE DIMESYLATE, TIRZEPATIDE, COLESEVELAM HYDROCHLORIDE, NORETHINDRONE, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, IRON, |
||||
| 986 | 26817656 |
US |
1 | |
Rash, Erythema, |
||||
PEGVALIASE-PQPZ, |
||||
| 987 | 26808971 |
US |
63 | 2 |
Oral herpes, Erythema, |
||||
DUPILUMAB, |
||||
| 988 | 26809244 |
US |
2 | |
Eye pain, Chest pain, Pain, Erythema, Cataract, Ocular discomfort, Eye pruritus, Off label use, |
||||
DUPILUMAB, |
||||
| 989 | 26809380 |
35 | ||
Tachycardia, Flushing, Chest pain, Ophthalmic migraine, Headache, Erythema, Off label use, |
||||
| 990 | 26809527 |
RU |
12 | 1 |
Body temperature increased, Headache, Dizziness, Vomiting, Erythema, Rash erythematous, |
||||
PROPRANOLOL HYDROCHLORIDE, VALPROIC ACID, |
||||
| 991 | 26809553 |
EU |
48 | 1 |
Infusion related reaction, Erythema, Malaise, Vomiting, |
||||
PANITUMUMAB, PANITUMUMAB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, |
||||
| 992 | 26809710 |
EU |
78 | |
Circulatory collapse, Nausea, Dizziness, Vomiting, Malaise, Abdominal distension, Tremor, Erythema, |
||||
ORAL SEMAGLUTIDE, |
||||
| 993 | 26809792 |
US |
72 | 2 |
Off label use, Alopecia, Bone pain, Arthralgia, Erythema, |
||||
OMALIZUMAB, OMALIZUMAB, VALSARTAN, VALSARTAN ORAL, |
||||
| 994 | 26809867 |
CA |
51 | 2 |
Pneumonia, Pain in extremity, Erythema, Skin warm, |
||||
DUPILUMAB, DUPILUMAB, TIOTROPIUM BROMIDE, CICLESONIDE, ALBUTEROL SULFATE, |
||||
| 995 | 26809869 |
US |
53 | 1 |
Hypersensitivity, Condition aggravated, Erythema, Skin warm, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 996 | 26809890 |
US |
19 | 2 |
Dermatitis atopic, Skin exfoliation, Erythema, Pruritus, |
||||
DUPILUMAB, FEXOFENADINE HYDROCHLORIDE, NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL, AND FERROUS FUMARATE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, CETIRIZINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL, AND FERROUS FUMARATE, FEXOFENADINE HYDROCHLORIDE, |
||||
| 997 | 26809932 |
BR |
69 | 1 |
Catheter site thrombosis, Catheter site infection, Acne, Erythema, Fatigue, Nodule, |
||||
PANITUMUMAB, RIVAROXABAN, ROSUVASTATIN, PANTOPRAZOLE, |
||||
| 998 | 26809978 |
2 | ||
Erythema, Pruritus, |
||||
LEVONORGESTREL, |
||||
| 999 | 26810062 |
JP |
67 | 1 |
Immune-mediated hepatic disorder, Rash, Immune-mediated enterocolitis, Erythema, Pyrexia, |
||||
PEMBROLIZUMAB, ENFORTUMAB VEDOTIN, |
||||
| 1000 | 26810101 |
US |
61 | 1 |
Erythema, |
||||
DUPILUMAB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30